Profil
Peter Halling is currently President & Chief Executive Officer at ALK-Abello A since 2024.
Mr. Halling is also Chief Financial Officer at Fertin Pharma A since 2020.
Mr. Halling graduated from Copenhagen Business School.
Aktive Positionen von Peter Halling
| Unternehmen | Position | Beginn |
|---|---|---|
| ALK-ABELLÓ A/S | Vorstandsvorsitzender | 01.01.2024 |
Fertin Pharma A/S
Fertin Pharma A/S Food: Specialty/CandyConsumer Non-Durables Develops and manufactures medical chewing gum products | Finanzdirektor/CFO | - |
Ausbildung von Peter Halling
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
ALK-Abello A/S
ALK-Abello A/S Pharmaceuticals: MajorHealth Technology Develops and produces, markets products for diagnosing, treating allergies, allergic asthma & acute anaphylactic reactions | Health Technology |
Copenhagen Business School
Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fertin Pharma A/S
Fertin Pharma A/S Food: Specialty/CandyConsumer Non-Durables Develops and manufactures medical chewing gum products | Consumer Non-Durables |
















